Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02998697

Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia (IRON5)

The Effect of Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia

Sponsor: National Cardiovascular Center Harapan Kita Hospital Indonesia

Conditions Heart Failure, Systolic Iron-deficiency Anemia

Interventions Ferrous Sulfate Placebo Oral Capsule

Updated 5 times since 2017 Last updated: Dec 19, 2016 Started: Jan 31, 2016 Primary completion: Oct 31, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02998697, this PHASE2/PHASE3 trial focuses on Heart Failure, Systolic and Iron-deficiency Anemia and remains completed. Sponsored by National Cardiovascular Center Harapan Kita Hospital Indonesia, it has been updated 5 times since 2016, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cardiovascular Center Harapan Kita Hospital Indonesia

Data source: National Cardiovascular Center Harapan Kita Hospital Indonesia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.